Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for Detection of Lung Cancer in Patients Undergoing Diagnostic or Therapeutic Bronchoscopy or Thoracotomy

NCT02715102 is registered in ClinicalTrials.gov with Pathway Genomics as lead sponsor.

NCT NCT02715102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02715102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for Detection of Lung Cancer in Patients Undergoing Diagnostic or Therapeutic Bronchoscopy or Thoracotomy
Lead sponsor
Pathway Genomics
Phase
Observational
Overall status
Terminated
Start date
June 30, 2016
Completion date
August 31, 2017
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the lung, cancer of the lung, lung cancer, lung neoplasms, non small cell carcinoma of the lung, small cell carcinoma of the lung